Bardon, Australia

Mark Gilroy

This inventor holds 2 USPTO granted patents. Top assignees: Ellume Limited, Modsel Pty Ltd.. Active years: 2021-2022.


% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark Gilroy: Innovator in Patient Conveyance Technology

Introduction

Mark Gilroy is an accomplished inventor based in Bardon, Australia. He has made significant contributions to the field of patient conveyance technology, holding a total of 2 patents. His innovative designs aim to improve the safety and efficiency of transporting patients.

Latest Patents

Among his latest patents is a sample collection device, which enhances the process of collecting samples in medical settings. Additionally, he has developed handles for a patient conveyance apparatus. This apparatus, which includes a transport chair or stretcher, features a frame that supports a patient with a lowering backrest. The design incorporates two handles that extend away from the frame, allowing them to be rotatable about two axes. This unique feature enables the handles to change their position and be moved through various operative and stowed positions without interfering with the movement of the backrest.

Career Highlights

Mark has worked with notable companies such as Modsel Pty Ltd. and Ellume Limited. His experience in these organizations has allowed him to refine his skills and contribute to advancements in medical technology.

Collaborations

Throughout his career, Mark has collaborated with talented individuals, including Sean Andrew Parsons and Lester Rowland. These partnerships have fostered innovation and creativity in his projects.

Conclusion

Mark Gilroy's contributions to patient conveyance technology demonstrate his commitment to improving healthcare solutions. His innovative patents and collaborations highlight his role as a significant figure in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…